<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846322</url>
  </required_header>
  <id_info>
    <org_study_id>2000029490</org_study_id>
    <secondary_id>U54AG063546</secondary_id>
    <nct_id>NCT04846322</nct_id>
  </id_info>
  <brief_title>Pathway to Detection &amp; Differentiation of Delirium &amp; Dementia in the Emergency Department</brief_title>
  <acronym>IMPACT</acronym>
  <official_title>Pathway to Detection &amp; Differentiation of Delirium &amp; Dementia in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study of the pragmatic implementation of an ED screening, outpatient&#xD;
      referral, and care coordination process for older ED patients who may have UCID.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Embedded pragmatic, implementation pilot that incorporates training, ED assessment for&#xD;
      delirium and dementia risk, referral of ED patients with undiagnosed cognitive impairment and&#xD;
      dementia for primary care feedback and care recommendations. This pilot would gather&#xD;
      observational data evaluating the feasibility of incorporating cognitive impairment screens&#xD;
      into routine ED delirium assessments, and developing optimal work flow for identifying and&#xD;
      referring ED patients with suspected (undiagnosed) dementia for confirmatory evaluation and&#xD;
      care coordination.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ED screening rates of delirium vs. suspected dementia</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patients 75+ screened / total number of ED visit by patients 75+</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Detection rates of delirium vs. suspected dementia</measure>
    <time_frame>30 days</time_frame>
    <description>daily number of patients discharged from ED with positive suspected dementia screen / number of patients 75+ screened.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rates of outpatient assessment referral of patients with suspected dementia</measure>
    <time_frame>30 days</time_frame>
    <description>number of patients with appointment to ADC or geriatrics outpatient clinic / number of patients given information sheet or referred to outpatient clinic</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rates of confirmed dementia or mild cognitive impairment</measure>
    <time_frame>30 days</time_frame>
    <description>number of patients positive for dementia or MCI / number of patients from ED seen at clinic with completion of UDS assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rates of connection with primary care</measure>
    <time_frame>30 days</time_frame>
    <description>number of patients with PCP follow-up about brain health plan / number of patients with outpatient confirmation of Dementia or MCI</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cognitive Impairment</condition>
  <condition>Emergency Care</condition>
  <condition>Dementia</condition>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>ED delirium &amp; dementia screening &amp; outpatient referral</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Routine ED screening for delirium and memory problems with referral for outpatient assessment of cognitive impairment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)</intervention_name>
    <description>ED assessment for suspected dementia.&#xD;
positive ED patients referred for outpatient clinic cognitive impairment assessment.&#xD;
positive clinic patients referred to primary care with brain health patient plan.</description>
    <arm_group_label>ED delirium &amp; dementia screening &amp; outpatient referral</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults age 65 or older&#xD;
&#xD;
          -  Discharged from the adult ED at YNHH or the ED at NMH&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented or known history of dementia&#xD;
&#xD;
          -  Alcohol/substance intoxication while in the ED&#xD;
&#xD;
          -  Non-English or Non-Spanish speaking&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ula Hwang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ula Hwang, MD</last_name>
    <phone>+1 (203) 7371774</phone>
    <email>ula.hwang@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lynne Iannone</last_name>
    <phone>+1 (203) 464-5460</phone>
    <email>lynne.iannone@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06512</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ula Hwang</last_name>
      <phone>203-737-1774</phone>
      <email>ula.hwang@yale.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Dresden, MD</last_name>
      <phone>312-926-6494</phone>
      <email>sdresden@nw.org</email>
    </contact>
    <contact_backup>
      <last_name>Kayla Muschong</last_name>
      <phone>312-926-6061</phone>
      <email>kayla.muschong@northwestern.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 25, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>delirium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

